GUTS 8-K: SEC filing
Fractyl Health, Inc.
Filed with the SEC on · accession 0001193125-26-458308
GUTS filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -7.8% by the first close after the filing.
Summary of the filing
Fractyl Health, Inc. announced its financial results for the quarter ended September 30, 2026 and provided a corporate update via a press release furnished as Exhibit 99.1 to this Form 8-K.
Key details
How GUTS stock reacted
Close before
$0.88
Nov 11, 2026
First close after
-7.84%
$0.81
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for GUTS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GUTS?
Click hereFrequently asked questions
What did GUTS file with the SEC on Nov 12, 2026?
GUTS filed a 8-K (SEC filing). Fractyl Health, Inc. announced its financial results for the quarter ended September 30, 2026 and provided a corporate update via a press release furnished as Exhibit 99.1 to this Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did GUTS stock react to this filing?
GUTS closed at $0.88 before the filing and $0.81 on Nov 12, 2026 (-7.84%).
Other GUTS SEC filings
- 10-Q · SEC filingNov 12, 2026
- 8-K · Board changeNov 6, 2026
- 8-K · Executive departureOct 22, 2026
- 8-K · Fda approvalOct 16, 2026
- SCHEDULE 13G · SEC filingOct 13, 2026
- 8-K · Stock splitOct 1, 2026
- 8-K · Stock splitSep 24, 2026
- 8-K · Delisting noticeSep 11, 2026
- DEF 14A · Board changeAug 24, 2026
- 10-Q · SEC filingAug 10, 2026
Get alerts when GUTS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days